CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

BSE 524715 SUNPHARMA INE044A01036
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 50NIFTY 500

Filing rhythm · 60 trading days

30 filings · 8 material · busiest 2026-07-31

What it files

Filings

30 in the window

  1. 25 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst/Institutional Investor Meeting

    Company Update / Analyst / Investor Meet View filing →

  2. 25 August 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    Notice of Postal Ballot/E-voting

    AGM/EGM / Postal Ballot View filing →

  3. 17 August 2026

    General

    Update On Lipitor Antitrust Litigation

    Update on Lipitor Antitrust Litigation

    Company Update / General View filing →

  4. 6 August 2026

    Concall Transcript

    Earnings Call Transcript

    Q1FY27 Earnings Call Transcript

    Company Update / Earnings Call Transcript View filing →

  5. 6 August 2026

    General

    Receipt Of No-Objection Letters From The Stock Exchanges For Reclassification Of Promoter Group

    Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group

    Company Update / General View filing →

  6. 5 August 2026

    Credit Rating

    Credit Rating

    Update on Credit Rating

    Company Update / Credit Rating View filing →

  7. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst/Institutional Investor Meeting

    Company Update / Analyst / Investor Meet View filing →

  8. 31 July 2026

    Results

    Unaudited Standalone And Consolidated Financial Results For Q1 Of FY 2026-27

    Quarterly Financial Results for Q1 of FY 2026-27

    Result / Financial Results View filing →

  9. 31 July 2026

    General

    Conclusion Of The Board Meeting Held Today, I.E., 31 July 2026

    Conclusion of the Board Meeting held today

    Company Update / General View filing →

  10. 31 July 2026

    General

    Q1FY27-Investor Call Audio Recording

    SPIL Q1FY27-Investor Call Audio Recording

    Company Update / General View filing →

  11. 31 July 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of the 34th Annual General Meeting held on 31 July 2026

    AGM/EGM / AGM View filing →

  12. 31 July 2026

    General

    Voting Results And Scrutinizer Report Of 34Th AGM Held On 31 July 2026

    Voting Results for 34th AGM

    Company Update / General View filing →

  13. 29 July 2026

    Press Release

    Press Release / Media Release

    Sun Pharma receives approval to manufacture and market semaglutide in Brazil

    Company Update / Press Release / Media Release View filing →

  14. 28 July 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper advertisement about opening of Special Window, for transfer of physical shares

    Company Update / Newspaper Publication View filing →

  15. 27 July 2026

    General

    Update On Nidlegy

    Update on Nidlegy

    Company Update / General View filing →

  16. 24 July 2026

    Press Release

    Press Release / Media Release

    Sun Pharma notes Organon Shareholder approval for proposed acquisition

    Company Update / Press Release / Media Release View filing →

  17. 15 July 2026

    Press Release

    Press Release / Media Release

    Press Release

    Company Update / Press Release / Media Release View filing →

  18. 14 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Sun Pharma to announce first quarter results on 31 July 2026 Earnings call scheduled on Friday, 06.30 pm IST, 31 July 2026

    Company Update / Analyst / Investor Meet View filing →

  19. 10 July 2026

    Board Meeting

    Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026

    Sun Pharmaceutical Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Unaudited Standalone ....

    Board Meeting / Board Meeting View filing →

  20. 7 July 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication

    Company Update / Newspaper Publication View filing →

  21. 7 July 2026

    Investor Presentation

    Investor Presentation

    Investor Presentation -June 2026

    Company Update / Investor Presentation View filing →

  22. 6 July 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report 2025-26 and the Notice of 34th Annual General Meeting

    Others / Reg. 34 (1) Annual Report View filing →

  23. 6 July 2026

    AGM / EGM

    Notice Of 34Th Annual General Meeting To Be Held On 31 July 2026 Along With The Annual Report For FY 2025-26

    Notice of 34th Annual General Meeting along with the Annual Report for FY 2025-26

    AGM/EGM / AGM View filing →

  24. 6 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Submission of Confirmation Certificate for the quarter ended 30 June 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  25. 26 June 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement

    Company Update / Newspaper Publication View filing →

  26. 25 June 2026

    Trading Window

    Closure of Trading Window

    Closure of trading window

    Insider Trading / SAST / Closure of Trading Window View filing →

  27. 16 June 2026

    Newspaper Publication

    Newspaper Publication

    Information about transfer of equity shares and unclaimed dividends to the Investor Education and Protection Fund (IEPF) Account

    Company Update / Newspaper Publication View filing →

  28. 12 June 2026

    Record Date

    Intimation Of Record Date For The Purpose Of Final Dividend For FY 2025-26

    Intimation of Record Date

    Corp. Action / Record Date View filing →

  29. 11 June 2026

    General

    Intimation Of 34Th Annual General Meeting And Record Date For Final Dividend And Connected Matters

    Intimation of 34th AGM and Record Date for Final Dividend

    Company Update / General View filing →

  30. 11 June 2026

    Dividend

    Corporate Action-Board to consider Dividend

    Intimation of Record Date for Final Dividend

    Corp. Action / Dividend View filing →